PRIZES to win! PROMOTIONS

Close Notification

Your cart does not contain any items

Disruptive Psychopharmacology

Frederick S. Barrett Katrin H. Preller

$445.95   $356.62

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
Springer International Publishing AG
28 August 2023
Psychedelic therapies are gaining traction as potential treatments for a wide range of indications, but the structure and delivery of psychedelic therapies are a sharp departure from more traditional models of psychotherapy and pharmacotherapy for psychiatric and other medical disorders. This may be critical to their success. The current volume provides a comprehensive review of the state of the science of psychedelic therapies, including discussion of models and approaches to psychedelic therapies as well as the current status of safety and efficacy data for mood, substance use, trauma, obsessive-compulsive, neurodevelopmental, neurodegenerative disorders, neurological, and inflammatory disorders.
Edited by:   ,
Imprint:   Springer International Publishing AG
Country of Publication:   Switzerland
Edition:   1st ed. 2022
Volume:   56
Dimensions:   Height: 235mm,  Width: 155mm, 
Weight:   522g
ISBN:   9783031121869
ISBN 10:   3031121864
Series:   Current Topics in Behavioral Neurosciences
Pages:   332
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Paperback
Publisher's Status:   Active
Dosing psychedelics and MDMA.- Psychedelic Group Therapy.- Set and Setting: Aesthetic experiences and their contribution to psychedelic therapies.- Psychedelic-Assisted Therapy for Social Adaptability in Autistic Adults.- Foundations for Training Psychedelic Therapists.- Ayahuasca for the Treatment of Depression.- Psilocybin for the Treatment of Depression.- Ketamine for the Treatment of Depression.- The Potential of Psychedelics for End of Life and Palliative Care.- Psychedelic-Assisted Therapy for Addiction and Potential Mechanisms of Action.- Psilocybin for Tobacco Use Disorder.- Psychedelic Drugs as Anti-Inflammatory Agents.- Psilocybin for the Treatment of Obsessive-Compulsive Disorder.- Psilocybin for the Treatment of Headache and Pain Disorders.- Psilocybin for the Treatment of Neurodegenerative Disorders.- Psilocybin for Trauma-Related Disorders.

See Also